Predictions
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€55.72
20.05.20
20.05.20
-
29.06.20
29.06.20
-13.57%
29.06.20
29.06.20
Pantaflix AG
Start price
Target price
Perf. (%)
€1.17
03.05.20
03.05.20
€10.00
04.11.21
04.11.21
11.59%
05.11.21
05.11.21
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Could be worthwhile Investment >10% per year
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€61.60
02.05.20
02.05.20
-
13.05.20
13.05.20
-5.00%
13.05.20
13.05.20
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€92.40
15.04.20
15.04.20
-
04.11.21
04.11.21
-71.21%
17.12.20
17.12.20
Pantaflix AG
Start price
Target price
Perf. (%)
€1.69
09.03.20
09.03.20
€8.00
03.05.20
03.05.20
-31.07%
03.05.20
03.05.20
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Could be worthwhile Investment >10% per year
Signaux Girod
Start price
Target price
Perf. (%)
€14.00
16.02.20
16.02.20
€15.00
04.11.21
04.11.21
10.71%
07.09.21
07.09.21
Could be worthwhile Investment >10% per year
Artnet AG NA
Start price
Target price
Perf. (%)
€4.26
10.02.20
10.02.20
-
04.11.21
04.11.21
106.57%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Undervalued
Very good company culture
Leading role in innovation
_wige MEDIA AG
Start price
Target price
Perf. (%)
€1.11
06.02.20
06.02.20
-
04.11.21
04.11.21
-34.84%
05.11.21
05.11.21
Standard Investments for future growth
Probably not worthwhile Investment
Increased challenges to pay loans and raise capital
Readcrest Capital AG
Start price
Target price
Perf. (%)
€0.45
21.12.19
21.12.19
€2.00
04.11.21
04.11.21
268.89%
17.05.21
17.05.21
Capable Management
Risky Investment
Business model of the past or high risk
Splendid Medien AG
Start price
Target price
Perf. (%)
€0.65
09.12.19
09.12.19
€1.00
04.11.21
04.11.21
103.08%
05.11.21
05.11.21
Pantaflix AG
Start price
Target price
Perf. (%)
€1.82
07.12.19
07.12.19
€8.00
09.03.20
09.03.20
-6.94%
09.03.20
09.03.20
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Could be worthwhile Investment >10% per year